PL2244783T3 - Kompozycje lotnego anestetyku i sposoby stosowania - Google Patents

Kompozycje lotnego anestetyku i sposoby stosowania

Info

Publication number
PL2244783T3
PL2244783T3 PL09704014T PL09704014T PL2244783T3 PL 2244783 T3 PL2244783 T3 PL 2244783T3 PL 09704014 T PL09704014 T PL 09704014T PL 09704014 T PL09704014 T PL 09704014T PL 2244783 T3 PL2244783 T3 PL 2244783T3
Authority
PL
Poland
Prior art keywords
methods
volatile anesthetic
anesthetic compositions
compositions
volatile
Prior art date
Application number
PL09704014T
Other languages
English (en)
Inventor
Allen Burton
Phillip C. Phan
Hatice Ozsoy
Christopher C. Capelli
Original Assignee
Board Of Regents, The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Regents, The University Of Texas System filed Critical Board Of Regents, The University Of Texas System
Publication of PL2244783T3 publication Critical patent/PL2244783T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09704014T 2008-01-22 2009-01-22 Kompozycje lotnego anestetyku i sposoby stosowania PL2244783T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1189808P 2008-01-22 2008-01-22
EP09704014.1A EP2244783B1 (en) 2008-01-22 2009-01-22 Volatile anesthetic compositions and methods of use
PCT/US2009/031707 WO2009094460A2 (en) 2008-01-22 2009-01-22 Volatile anesthetic compositions and methods of use

Publications (1)

Publication Number Publication Date
PL2244783T3 true PL2244783T3 (pl) 2020-08-24

Family

ID=40901623

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09704014T PL2244783T3 (pl) 2008-01-22 2009-01-22 Kompozycje lotnego anestetyku i sposoby stosowania

Country Status (10)

Country Link
US (3) US20110159078A1 (pl)
EP (1) EP2244783B1 (pl)
JP (2) JP5835542B2 (pl)
CN (1) CN102006903A (pl)
AU (1) AU2009206391A1 (pl)
CA (1) CA2712516C (pl)
DK (1) DK2244783T3 (pl)
ES (1) ES2765007T3 (pl)
PL (1) PL2244783T3 (pl)
WO (1) WO2009094460A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010504359A (ja) 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および／または疼痛緩和のための、揮発性麻酔剤を送達するための方法
CA2712731C (en) 2008-01-22 2016-05-03 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
US20110159078A1 (en) * 2008-01-22 2011-06-30 Vapogenix, Inc Volatile Anesthetic Compositions and Methods of Use
WO2010025505A1 (en) * 2008-09-04 2010-03-11 Phebra Pty Ltd Analgesia by transmucosal administration
US9744142B2 (en) * 2009-05-05 2017-08-29 Board Of Regents, The University Of Texas Systems Formulations of volatile anesthetics and methods of use for reducing inflammation
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
DE102010042615A1 (de) 2010-10-19 2012-04-19 Wacker Chemie Ag 1:1, 2:1- oder 3:1-Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem halogeniertem Ether, seine Herstellung und seine Verwendung als Schlafmittel
CA2839670C (en) * 2011-06-20 2016-05-24 Dmf Medical Incorporated An anesthetic circuit and a method for using the anesthetic circuit
CN107260670A (zh) 2011-06-24 2017-10-20 维普詹尼克斯公司 用于治疗皮肤病症或疾病的新型制剂和方法
US11083696B2 (en) * 2011-09-21 2021-08-10 University College Cardiff Consultants Limited Dispersion anaesthetic device
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
EP2934645B1 (en) 2012-12-22 2019-08-21 DMF Medical Incorporated An anesthetic circuit having a hollow fiber membrane
CA3179312C (en) 2013-03-15 2025-07-08 Vapogenix, Inc. ANALGESIC COMPOSITIONS COMPRISING HALOGENATED VOLATILE COMPOUNDS
RU2720158C2 (ru) 2015-07-20 2020-04-24 Медикал Дивелопментс Интернэшнл Лимитед Ингаляторное устройство для ингаляционных жидкостей
JP7001589B2 (ja) 2015-07-20 2022-01-19 メディカル、ディベロップメンツ、インターナショナル、リミテッド 吸入可能な液体のための吸入器デバイス
US10213574B2 (en) 2015-07-20 2019-02-26 Medical Developments International Limited Inhaler device for inhalable liquids
US11571526B2 (en) 2016-09-06 2023-02-07 Medical Developments International Limited Inhaler device for inhalable liquids
US12480926B2 (en) 2018-03-19 2025-11-25 Trustees Of Boston University Systems, devices, and methods for ultrasonic agitation mediated kinetic release testing of compounds
AU2021283452A1 (en) 2020-06-02 2023-01-19 Medical Developments International Limited Inhaler device for inhalable liquids

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879062A (en) * 1981-10-20 1989-11-07 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5114715A (en) 1990-11-29 1992-05-19 Sepracor Inc. Methods of use and compositions of (s)-isoflurane and (s)-desflurane
US5114714A (en) 1990-11-29 1992-05-19 Sepracor, Inc. Methods of use and compositions of (r)-isoflurane and (r)-desflurane
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
BE1005163A3 (fr) 1991-08-01 1993-05-11 Solvay Compositions contenant un ether fluore et utilisation de ces compositions.
US5283372A (en) 1991-12-04 1994-02-01 Anaquest, Inc. Preparation of purified optical isomers of desflurane
US5230778A (en) * 1992-05-01 1993-07-27 Gavlin Associates Purification of isoflurane by extractive distillation
IL122249A0 (en) * 1995-06-07 1998-04-05 Alliance Pharmceutical Corp Fluorocarbon pharmaceutical formulations and their preparation
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5861175A (en) * 1996-03-15 1999-01-19 Alliance Pharmaceutical Corp. Use of fluorocarbons for diagnosis and treatment of articular disorders
DE19709704C2 (de) 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US20030152637A1 (en) * 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
US20030027833A1 (en) * 2001-05-07 2003-02-06 Cleary Gary W. Compositions and delivery systems for administration of a local anesthetic agent
HK1079703A1 (zh) 2002-10-11 2006-04-13 巴克斯特国际公司 通过静脉施用卤化挥发性麻醉药保护心脏和保护神经的方法
CA2530407A1 (en) * 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
AU2004280118B2 (en) * 2003-10-10 2009-01-15 Imperial Innovations Limited Use of xenon with hypothermia for treating neonatal asphyxia
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
JP2010504359A (ja) * 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および／または疼痛緩和のための、揮発性麻酔剤を送達するための方法
EP2099408B1 (en) * 2006-11-28 2016-10-05 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
CA2712731C (en) 2008-01-22 2016-05-03 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
US20110159078A1 (en) * 2008-01-22 2011-06-30 Vapogenix, Inc Volatile Anesthetic Compositions and Methods of Use
US9744142B2 (en) 2009-05-05 2017-08-29 Board Of Regents, The University Of Texas Systems Formulations of volatile anesthetics and methods of use for reducing inflammation

Also Published As

Publication number Publication date
CA2712516C (en) 2016-06-28
CN102006903A (zh) 2011-04-06
JP2011510092A (ja) 2011-03-31
DK2244783T3 (da) 2020-03-16
WO2009094460A3 (en) 2009-12-30
JP2014240420A (ja) 2014-12-25
CA2712516A1 (en) 2009-07-30
US20130273141A1 (en) 2013-10-17
AU2009206391A1 (en) 2009-07-30
US20170112783A1 (en) 2017-04-27
EP2244783B1 (en) 2019-12-18
US20110159078A1 (en) 2011-06-30
WO2009094460A2 (en) 2009-07-30
JP5952357B2 (ja) 2016-07-13
EP2244783A4 (en) 2011-03-09
EP2244783A2 (en) 2010-11-03
JP5835542B2 (ja) 2015-12-24
ES2765007T3 (es) 2020-06-05
US9566251B2 (en) 2017-02-14

Similar Documents

Publication Publication Date Title
PL2244783T3 (pl) Kompozycje lotnego anestetyku i sposoby stosowania
GB2469245B (en) Antimicrobial compositions and methods of use thereof
IL245172A0 (en) Pharmaceutical preparations and methods for transferring them related to them
IL208858A0 (en) Lipid-containing compositions and methods of use thereof
IL209507A0 (en) Antimicrobial compositions and methods of use thereof
PL2346327T3 (pl) Kompozycje biobójcze i sposoby stosowania
SI2320911T1 (sl) Vazokonstrikcijski sestavki in metode uporabe
EP2448581A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS OF USE THEREOF
EP2334185A4 (en) COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
IL202684A0 (en) Anti-cd20 therapeutic compositions and methods of use thereof
ZA201104463B (en) Compounds and methods of use
EP2326171A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
IL206835A0 (en) Methods and compositions for oral administration of insulin
EP2346324A4 (en) ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING
EP2271750A4 (en) URICASE COMPOSITIONS AND METHODS OF USE
IL201364A0 (en) Gas-effusing compositions and methods of making and using same
EP2139909A4 (en) PREQ1-RIBOSWITCHES AND METHOD AND COMPOSITIONS FOR USE BY AND WITH PREQ1-RIBOSWITCHES
ZA201102207B (en) Cinnamandehyde-allicin compositions and their method of use
GB0823497D0 (en) Immunogenic composition and use thereof
IL207827A0 (en) Apoaequorin-containing compositions and methods of using same
PL2498613T3 (pl) Kompozycje biobójcze i sposoby ich stosowania
ZA201004894B (en) Nuctraceutical composition and methods of use
EP2381950A4 (en) COMPOSITIONS AND METHOD FOR THEIR USE